BioVersys AG (SWX:BIOV)
Switzerland
· Delayed Price · Currency is CHF
23.00
-1.90 (-7.63%)
At close: Mar 9, 2026
BioVersys AG Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Debt / Equity Ratio | 0.26 | 1.59 | 1.86 |
| Net Debt / Equity Ratio | -1.06 | -1.46 | -1.45 |
| Net Debt / EBITDA Ratio | 4.18 | 0.84 | 0.71 |
| Net Debt / FCF Ratio | 4.42 | 1.00 | 1.06 |
| Asset Turnover | - | 0.04 | - |
| Quick Ratio | 9.02 | 3.51 | 3.25 |
| Current Ratio | 9.24 | 3.56 | 3.59 |
| Return on Equity (ROE) | - | -194.40% | - |
| Return on Assets (ROA) | - | -33.87% | - |
| Return on Capital Employed (ROCE) | -21.00% | -74.10% | -71.40% |
| Buyback Yield / Dilution | - | -11.60% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.